Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Orvosi Hetilap|July 21, 2009
[Does carbohydrate-deficient transferrin have diagnostic value in non-alcoholic fatty liver disease?]Emil Fraenkel, György Szabó, Gabriella Lengyel, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Redox Homeostasis and Non-Invasive Assessment of Significant Liver Fibrosis by Shear Wave ElastographyAnna Egresi, Anna Blázovics, Gabriella Lengyel, et al.
Orvosi Hetilap|July 27, 2014
[Plasmapheresis in the treatment of hypertriglyceridemia]Tatjána Ábel, Katalin Sándor, Anna Tremmel, et al.
Orvosi Hetilap|January 12, 2005
[Hepatitis C virus RNA in the skin eruption from patients with prurigo and chronic hepatitis C]Beáta Podányi, András Kiss, Pál Kaposi Novák, et al.
Orvosi Hetilap|August 22, 2020
The potential role of organic and conventional yoghurt consumption in the treatment of non-alcoholic fatty liver diseaseAnna Egresi, Dóra Drexler, Krisztina Hagymási, et al.
Orvosi Hetilap|March 18, 2014
[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline]Gábor Horváth, Béla Hunyady, Judit Gervain, et al.
Orvosi Hetilap|May 30, 2012
[Effect of "Pintes" white wine on metabolic parameters in patients with metabolic syndrome]Tatjána Abel, Anna Blázovics, Alexandra Wimmer, et al.
Orvosi Hetilap|March 21, 2012
[Carbohydrate-deficient transferrin in doping and non-doping athletes]György Szabó, Emil Fraenkel, Gergely Szabó, et al.
Orvosi Hetilap|February 3, 2004
[Combined interferon-alfa-2b and ribavirin therapy in patients with recurrent chronic hepatitis c after liver transplantation]Gabriella Lengyel, László Kóbori, Imre Fehérvári, et al.
Plos One|September 1, 2010
Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarkerGábor Firneisz, Tímea Varga, Gabriella Lengyel, et al.
Pageof 9